Use of Hyaluronic Acid-enriched Transfer Medium in Women Undergoing Single Blastocyst Transfer : a Multicenter, Randomized Controlled Trial
Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this study is to compare the live birth rates of high concentration of Hyaluronic Acid (0.5 mg/ml) transfer medium (EmbryoGlue®) to those containing low Hyaluronic Acid concentrations (0.125 mg/ml) (G2 medium) in women undergoing single fresh and frozen blastocyst transfer.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• All cycles with single blastocyst transfer will be considered eligible
• Both fresh and cryopreserved embryo transfer cycles utilizing autologous oocytes
• No age restriction will be applied
• Informed consent was signed
Locations
Other Locations
China
IVF laboratory
RECRUITING
Xi'an
Contact Information
Primary
He Cai, Doctor
caihe@bjmu.edu.cn
13581613908
Time Frame
Start Date: 2024-09-13
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 858
Treatments
Experimental: Hyaluronic Acid(EmbryoGlue®)
High HA concentrations (0.5 mg/ml)
Active_comparator: Hyaluronic Acid (G2 medium)
Low HA concentrations (0.125 mg/ml)
Related Therapeutic Areas
Sponsors
Collaborators: Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Gansu Provincial Maternal and Child Health Care Hospital, Jiangxi Maternal and Child Health Hospital
Leads: Northwest Women's and Children's Hospital, Xi'an, Shaanxi